Risk-guided cardioprotection with carvedilol in patients with breast cancer (CCT guide): a phase 1 randomized clinical trial.

Jung W, Hubbard RA, Smith AM, Ko K, Huang A, Wang J, Isaacs JM, Zhang L, Liu PP, Chen Z, Shah PD, Mintzer D, Bhattacharya S, Knollman HM, Clark AS, Koropeckyj-Cox D, Messinger M, Wilcox NS, Xia C, Narayan V, Upshaw JN, Armenian SH, Ky B

Open source

DOI: 10.1007/s10549-025-07636-3
Published: 2025 Jun
Container: Breast cancer research and treatment
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1007/s10549-025-07636-3,
  title = {Risk-guided cardioprotection with carvedilol in patients with breast cancer (CCT guide): a phase 1 randomized clinical trial.},
  author = {Jung W and Hubbard RA and Smith AM and Ko K and Huang A and Wang J and Isaacs JM and Zhang L and Liu PP and Chen Z and Shah PD and Mintzer D and Bhattacharya S and Knollman HM and Clark AS and Koropeckyj-Cox D and Messinger M and Wilcox NS and Xia C and Narayan V and Upshaw JN and Armenian SH and Ky B},
  year = {2025},
  journal = {Breast cancer research and treatment},
  doi = {10.1007/s10549-025-07636-3},
  url = {https://doi.org/10.1007/s10549-025-07636-3}
}

RIS

TY  - JOUR
TI  - Risk-guided cardioprotection with carvedilol in patients with breast cancer (CCT guide): a phase 1 randomized clinical trial.
AU  - Jung W
AU  - Hubbard RA
AU  - Smith AM
AU  - Ko K
AU  - Huang A
AU  - Wang J
AU  - Isaacs JM
AU  - Zhang L
AU  - Liu PP
AU  - Chen Z
AU  - Shah PD
AU  - Mintzer D
AU  - Bhattacharya S
AU  - Knollman HM
AU  - Clark AS
AU  - Koropeckyj-Cox D
AU  - Messinger M
AU  - Wilcox NS
AU  - Xia C
AU  - Narayan V
AU  - Upshaw JN
AU  - Armenian SH
AU  - Ky B
PY  - 2025
JO  - Breast cancer research and treatment
DO  - 10.1007/s10549-025-07636-3
UR  - https://doi.org/10.1007/s10549-025-07636-3
ER  -

APA

W, J., RA, H., AM, S., K, K., A, H., J, W., JM, I., L, Z., PP, L., Z, C., PD, S., D, M., S, B., HM, K., AS, C., D, K., M, M., NS, W., C, X., V, N., JN, U., SH, A., & B, K. (2025). Risk-guided cardioprotection with carvedilol in patients with breast cancer (CCT guide): a phase 1 randomized clinical trial.. Breast cancer research and treatment. https://doi.org/10.1007/s10549-025-07636-3

Source records

pubmed · retrieved 2026-09-27T12:47:09.043Z